EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...

Merit Medical Systems, Inc. MMSI recently announced the launch of its new Ventrax Delivery System, designed to enhance precision and control in pulmonary interventions. This latest innovation reflects ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...

South Jordan, Utah–based Merit adds the latest delivery system to its growing electrophysiology (EP) and cardiac rhythm management (CRM) portfolio. It joins solutions such as HeartSpan, Worley, ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

SOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced the US commercial release of its Ventrax ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Systems announced the US commercial release of its Ventrax Delivery System. The new delivery system is Merit’s latest ...

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy ...

A team at CNIC has developed an innovative gene therapy to treat arrhythmogenic right ventricular cardiomyopathy type 5 ...